Meda’s annual report is published

Meda has today published its annual report for 2013 on The printed version will be distributed to shareholders later in April.

For further inquiries, please contact:

Paula Treutiger, Investor Relations                                                                                ph: +46 733-666 599                                                                                                                                                                                                        

Meda AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on April 2, 2014, at 15:30 CET.

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 120 countries worldwide and the company is represented by its own organizations in over 55 countries. The Meda share is listed under
Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.